Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Simvastatin on the Prognosis of Primary Sclerosing Cholangitis (PSC); A Randomized, Double-blind, Placebo Controlled Multicenter Study

NCT04133792 is registered in ClinicalTrials.gov with Annika Bergquist as lead sponsor.

NCT NCT04133792
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04133792 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Simvastatin on the Prognosis of Primary Sclerosing Cholangitis (PSC); A Randomized, Double-blind, Placebo Controlled Multicenter Study
Lead sponsor
Annika Bergquist
Phase
Phase 3
Overall status
Active, not recruiting
Start date
October 1, 2020
Completion date
March 31, 2030
Enrollment
571 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

primary sclerosing cholangitis